Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Stents Market Size Likely To Evolve From 2025 Through 2034?
The valuation of the stents sector has demonstrated consistent expansion over the past few years, projected to increase from $11.26 billion in 2024 to $11.81 billion in 2025, reflecting a compound annual growth rate of 4.8%. This historical upswing is fundamentally linked to several factors: the escalating incidence of heart-related ailments, an aging global demographic, heightened recognition regarding less invasive surgical techniques, expanding public spending on health services, greater utilization of drug-eluting stents, and a greater frequency of angioplasty operations being performed.
Projections indicate robust expansion for the stents sector over the coming years, with the market value anticipated to reach $14.77 billion by the year 2029, reflecting a consistent compound annual growth rate of 5.8%. This upward trajectory during the forecast interval is underpinned by several key factors, such as escalating government support for healthcare programs, the mounting incidence of diabetes, a growing patient pool deemed high-risk, heightened consumer desire for stents tailored to individual needs, and more frequent partnerships forged between medical technology companies and healthcare institutions. Current significant movements shaping this period involve novel developments in stent engineering, the development of healthcare facilities in developing economies, the emergence of stents manufactured via 3D printing, the introduction of smaller stents designed for narrower blood vessels, and the utilization of robotic assistance for stent placement procedures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24408&type=smp
Which Industry Drivers Are Expected To Accelerate The Stents Market From 2025 To 2029?
Anticipated increases in ailments affecting the heart and blood vessels are projected to boost the expansion of the stents industry moving ahead; these conditions, which impede optimal cardiac function, are often linked to sedentary lifestyles contributing to elevated body weight, hypertension, and general poor circulatory wellness by diminishing the effectiveness of the heart and its distribution system. The implementation of stents plays a vital role in managing these cardiovascular issues by successfully reopening and preserving circulation through arteries that have become constricted or obstructed, consequently mitigating the likelihood of myocardial infarctions and related negative outcomes. To illustrate this urgency, data from the British Heart Foundation, a charity dedicated to cardiovascular research in the United Kingdom, indicated that as of January 2025, approximately 7.6 million individuals across the UK were managing heart and circulatory diseases, comprising roughly 4 million males and 3.6 million females; these serious health challenges account for nearly one-quarter of all national mortalities, causing more than 170,000 deaths annually, which equates to around 480 lost lives daily, thus providing a clear impetus for the expansion within the stent market due to the escalating prevalence of cardiovascular problems.
What Are The Major Segments Identified In The Stents Market?
The stentsmarket covered in this report is segmented –
1) By Product: Coronary Stents, Peripheral Stents, Stent-Related Implants, Biliary Stents, Carotid Stents, Neurovascular Stents
2) By Material: Metallic Biomaterial, Polymer Biomaterial, Natural Biomaterial
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End User
Subsegments:
1) By Coronary Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents
2) By Peripheral Stents: Iliac Artery Stents, Femoral-Popliteal Artery Stents, Renal Artery Stents, Tibial Artery Stents
3) By Stent-Related Implants: Stent Grafts, Endovascular Stent Grafts, Covered Stents
4) By Biliary Stents: Plastic Biliary Stents, Metallic Biliary Stents, Self-Expanding Biliary Stents
5) By Carotid Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents
6) By Neurovascular Stents: Flow Diverter Stents, Self-Expanding Neurovascular Stents, Balloon-Expandable Neurovascular Stents
Which Ongoing Trends Are Expected To Shape The Stents Market Outlook?
Leading firms within the stent industry are concentrating efforts on creating novel solutions, particularly drug-eluting stents, aiming to boost effectiveness, lower the recurrence of artery blockage, and achieve better clinical results for patients; these devices are essentially diminutive, tubular mesh structures inserted into blood vessels that dispense medication gradually to discourage re-narrowing post-treatment. A clear example of this industry trend is Medtronic plc, an Irish medical device giant, which, subsequent to securing CE Mark authorization in August 2022, introduced its newest drug-eluting coronary stent creation, named Onyx Frontier; this advanced stent utilizes the established Resolute Onyx foundation but integrates superior features such as a novel bi-layered balloon, a reduced profile for navigating tight spaces, and greater catheter pliability, culminating in a 16% improvement in ease of placement over its predecessor, all while preserving its structural integrity; furthermore, the Onyx Frontier boasts an extensive selection of diameters, spanning from 2.0mm up to 5.0mm, with the larger 4.50–5.00mm variants capable of expanding further, up to 6.00mm, a configuration specifically engineered to accommodate exceptionally wide arteries, notably the left main coronary artery.
Which Major Industry Participants Are Leading The Stents Market Growth?
Major companies operating in the stents market are Abbott Laboratories, Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Teleflex Incorporated, Cook Group Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Micro-Tech Europe, Meril Life Sciences, MicroPort Scientific Corporation, Biosensors International Group Ltd., Novatech SA, Elixir Medical Corporation, Vascular Concepts Ltd., Veryan Medical Limited
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/stents-global-market-report
How Do Regional Market Performances Compare Within The Stents Industry?
North America was the largest region in the stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Stents Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24408&type=smp
Browse Through More Reports Similar to the Global Stents Market 2025, By The Business Research Company
Bioabsorbable Stents Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report
Intracranial Stents Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
